Axogen, Inc.AXGN财报
Nasdaq · 医疗保健 · 电子医疗与电疗设备
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| First Light Asset Management, LLC | 9.96% | 4.4M | — | 2024-11-07 |
| BlackRock, Inc. | 7.80% | 3.3M | — | 2024-01-26 |
| NOS. OF ABOVE PERSONS | 6.80% | 3.0M | ▲ +0.80pp | 2024-11-14 |
| ArrowMark Colorado Holdings, LLC | 6.14% | 2.7M | ▼ -5.83pp | 2024-09-10 |
| The Vanguard Group | 5.73% | 2.5M | — | 2024-02-13 |
内部人交易
Net 90d: −$171.5K · buys $0 / sells $171.5K时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Option exercise | 6.4K | $0.00 | $0 |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Option exercise | 11.6K | $0.00 | $0 |
| 2026-03-16 | DeVinney Erick Wayne | Chief Innovation Officer | Sell (open market) | 5.2K | $32.84 | $171.5K |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Option exercise | 4.0K | $0.00 | $0 |
| 2026-03-16 | Hartley Lindsey Marie | CFO | Option exercise | 5.0K | $0.00 | $0 |
| 2026-03-01 | Began Marc A | EVP & General Counsel | Option exercise | 11.3K | $0.00 | $0 |
| 2026-02-26 | DeVinney Erick Wayne | Chief Innovation Officer | Grant | 33.8K | $0.00 | $0 |
| 2026-02-26 | Jens Kemp | Chief Marketing Officer | Grant | 50.7K | $0.00 | $0 |
| 2026-02-26 | Began Marc A | EVP & General Counsel | Grant | 33.8K | $0.00 | $0 |
| 2026-02-26 | Hartley Lindsey Marie | CFO | Grant | 17.5K | $0.00 | $0 |
1–10 of 11
第 1 页 / 共 2 页